Cargando…
Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy
There is a dire need for reliable biomarkers to solidify an early and accurate diagnosis of multiple system atrophy (MSA). We sought to compare the ability of emerging plasma markers in distinguishing MSA from its mimics and healthy controls in early disease stages, and to evaluate their performance...
Autores principales: | Guo, Yu, Shen, Xue-Ning, Huang, Shu-Yi, Chen, Shu-Fen, Wang, Hui-Fu, Zhang, Wei, Zhang, Ya-Ru, Cheng, Wei, Cui, Mei, Dong, Qiang, Yu, Jin-Tai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017699/ https://www.ncbi.nlm.nih.gov/pubmed/36922526 http://dx.doi.org/10.1038/s41531-023-00481-5 |
Ejemplares similares
-
The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023) -
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy
por: Yang, Xiao-Li, et al.
Publicado: (2023) -
Deamidation-related blood biomarkers show promise for early diagnostics of neurodegeneration
por: Wang, Jijing, et al.
Publicado: (2022) -
Genome-wide association study of hippocampal atrophy rate in non-demented elders
por: Guo, Yu, et al.
Publicado: (2019) -
Susceptibility of Multiple Primary Cancers in Patients With Head and Neck Cancer: Nature or Nurture?
por: Zhang, Wei-long, et al.
Publicado: (2019)